This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Welcome to BPI Europe 2024!
9-12 April 2024Messe Wien Congress Centre, Vienna

Novo Nordisk Pharmatech A/S

Profile

Novo Nordisk Pharmatech A/S is a global and leading manufacturer of ingredients for the biopharmaceutical and pharmaceutical industries. The company specializes in cGMP-manufactured Recombinant Insulin, Superior Enzymes, Customised Resins, and quaternary ammonium compounds (Quats).

Recombinant Insulin is a versatile ingredient for the manufacturing of a broad range of different therapeutic therapies, from monoclonal antibodies to cell and gene therapies and vaccines, and is approved by regulatory bodies worldwide, including FDA and EMA.

Thanks to the superior quality and reliable supply, Novo Nordisk Pharmatech supplies recombinant insulin as an ingredient for the biomanufacturing of more than 100 therapeutic drugs currently available in the market. The mission is to enable better medicines.

The high-purity, non-therapeutic recombinant insulin is sourced directly from parent company Novo Nordisk, celebrating its 100th anniversary in 2023.